DNA Dividende : Ginkgo Bioworks Holdings Inc Analyse du rendement



Dividendes

DNA Dividendes

Ginkgo Bioworks Holdings Inc

$8.67

-2.91%

$-0.25

À la fermeture : May 11, 16:00:00 GMT-4

$8.81

1.61%

$0.14

Post-Marché: May 11, 20:00:00 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$8.93

Prix d'ouverture

$8.71

Plage de la journée

$8.41 - $9.04

Plage de 52 semaines

$5.37 - $17.58

Volume

1.6M

Volume moyen

1.1M

Rendement en dividend

BPA (TTM)

-5.64

Capitalisation boursière

$519.0M

Qu’est-ce que DNA ?

Ginkgo Bioworks Holdings, Inc. is a biotech company. The company is headquartered in Boston, Massachusetts and currently employs 485 full-time employees. The company went IPO on 2021-04-19. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The firm provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.